Bifidobacterium longum – 04 (DSM 23233)

    Cardiology blend | Cholesterol management

    • Bifidobacterium lactis – MB2409 (DSM 23733)
    • Bifidobacterium bifidum – MB109 (DSM 23731)
    • Bifidobacterium longum – 04 (DSM 23233)

    Characteristics

    DAILY DOSAGE IN CLINICAL STUDY
    1 billion CFU/strain

    FUNCTIONALITY
    Cardiovascular health • Cholesterol lowering

    Scientific support

    Human clinical trial
    Guardamagna O. et al. Bifidobacteria supplementation: effects on plasma lipid profile in dyslipidemic children. Nutrition (2014), doi: 10.1016/ j.nut. 2014.01.014.

    In vitro and in vivo testing
    Bordoni et al. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of Bifidobacteria. Appl. Microbiol. Biotechnol. 2013. 97:8273-8281.


    Dietetics strain | Weight management

    Characteristics

    DAILY DOSAGE
    1 billion CFU

    FUNCTIONALITY
    Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production • Prospective use in the treatment of obesity • Cholesterol management

    Scientific support

    Internal data available upon request


    Gut-brain blend | Mood and sleep quality

    • Bifidobacterium longum – 04 (DSM 23233)
    • Lactobacillus fermentum – LF16 (DSM 26856)
    • Lactobacillus plantarum – LP01 (LMG P-21021)
    • Lactobacillus rhamnosus – LR06 (DSM 21981)

    Characteristics

    DAILY DOSAGE IN CLINICAL STUDY
    1 billion cfu/afu per strain

    FUNCTIONALITY
    Improvement of the quality of sleep • Reduction of fatigue and anger • Improvement of mood • Inhibition of E. coli and Candida

    Scientific support

    Human clinical trial
    Marotta A. et al., Effects of Probiotics on Cognitive Reactivity, Mood, and Sleep Quality, 2019 Frontiers in Psychiatry.